Xior Student Housing NV (XIOR)
Euronext Brussels · Belgium · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 23.80 |
|---|---|
| 52-week range | 22.80 – 30.50 |
| Return, 1 month / 3 months | −6.3% / −14.8% |
| Return, 1 year / 3 years | −15.8% / +12.3% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 16.8% |
| Worst drawdown (1 year) | -21.1% |
| Average daily value traded | 1.46M EUR |
| Dividend yield | 3.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Xior Student Housing is a Belgian real estate company that owns and rents out student accommodation. It provides rooms, studios and shared apartments to students and young professionals, mainly in university cities across Belgium and other parts of Europe. The company is based in Belgium and operates as a regulated real estate investment trust, managing its properties and collecting rent from tenants who need housing near their places of study.
The shares are listed on the Euronext Brussels in Belgium under the code XIOR, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Xior Student Housing NV (XIOR) trades on the Euronext Brussels in Belgium. It last closed at EUR 23.80 on 22 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 59 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.8% and over the last three months it fell 14.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -10.9% | ||
| From 52-week high | -20.9% | ||
| Momentum | 29 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.8% | ||
| 6-month return | -10.6% | ||
| 12-month return, skipping the last month | -10.2% | ||
| Stability (higher is calmer) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 16.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.1% | ||
| Liquidity | 73 · Strong | Trades actively. | |
| Average daily value traded | 1.46M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 74 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.7% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +0.8% |
|---|---|
| 1 month | −6.3% |
| 3 months | −14.8% |
| 6 months | −10.6% |
| 1 year | −15.8% |
| 3 years | +12.3% |
| 5 years | −37.4% |
Signals
| 50-day / 200-day average | 25.23 / 26.72 |
|---|---|
| Golden / death cross (60 days) | Death, 27 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.45 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 May 2026 | EUR 0.8884 |
| 15 Apr 2025 | EUR 1.2463 |
| 10 Apr 2025 | EUR 0.3492 |
| 17 Jan 2025 | EUR 0.8724 |
| 20 May 2024 | EUR 1.2103 |
| 21 Apr 2024 | EUR 0.8511 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.